No statutes or acts will be found at this website.
The Pennsylvania Bulletin website includes the following: Rulemakings by State agencies; Proposed Rulemakings by State agencies; State agency notices; the Governor’s Proclamations and Executive Orders; Actions by the General Assembly; and Statewide and local court rules.
• No statutes or acts will be found at this website.
The Pennsylvania Bulletin website includes the following: Rulemakings by State agencies; Proposed Rulemakings by State agencies; State agency notices; the Governor’s Proclamations and Executive Orders; Actions by the General Assembly; and Statewide and local court rules.
Updates to the Medical Assistance Program Fee Schedule for Administration of a Booster Dose of the SARS-CoV-2 Vaccine Manufactured by Novavax
PA Bulletin, Doc. No. 23-611
NOTICES
DEPARTMENT OF HUMAN SERVICES
Updates to the Medical Assistance Program Fee Schedule for Administration of a Booster Dose of the SARS-CoV-2 Vaccine Manufactured by Novavax
[53 Pa.B. 2500] [Saturday, May 6, 2023]
In accordance with 55 Pa. Code § 1150.61(a) (relating to guidelines for fee schedule changes), the Department of Human Services (Department) announces the addition of the following procedure code to the Medical Assistance (MA) Program Fee Schedule for the administration of a booster dose of the SARS-CoV-2 vaccine manufactured by Novavax. The effective date and MA fee are indicated as follows.
Procedure Code
Description
Effective Date
MA Fee
0044A
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease (COVID-19)) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster dose
10/19/22
$40
The MA Program Fee Schedule has been updated with the new Current Procedural Terminology (CPT) code to allow for payment of the administration of a booster dose of the SARS-CoV-2 vaccine manufactured by Novavax.
The Department issued an MA Bulletin to inform providers enrolled in the MA Program of the addition of the CPT code for the administration of a booster dose of the SARS-CoV-2 vaccine manufactured by Novavax.
Fiscal Impact
There is no fiscal impact associated with the addition of this procedure code.
Public Comment
Interested persons are invited to submit written comments to the Department of Human Services, Office of Medical Assistance Programs, c/o Regulations Coordinator, P.O. Box 2675, Harrisburg, PA 17120, RA-PWMAProgComments@pa.gov. Comments received within 30 days will be reviewed and considered for any subsequent revision of the MA Program Fee Schedule.
Persons with a disability who require an auxiliary aid or service may submit comments using the Pennsylvania Hamilton Relay Service at (800) 654-5984 (TDD users) or (800) 654-5988 (voice users).
VALERIE A. ARKOOSH,
Acting Secretary
Fiscal Note: 14-NOT-1568. No fiscal impact; recommends adoption.
[Pa.B. Doc. No. 23-611. Filed for public inspection May 5, 2023, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official
Pennsylvania Bulletin full text database.
Due to the limitations of HTML or differences in display capabilities
of different browsers, this version may differ slightly from the
official printed version.
